Hierarchical Analysis Of Recurrent Point Mutations In SF3B1 and TET2 In RARS Stem Cells

被引：0
|
作者：
Mortera-Blanco, Teresa
Dimitriou, Marios
Woll, Petter
Karimi, Mohsen
Papaemmanuil, Elli
Conte, Simona
Chowdhuri, Oni
Jansson, Monika
Campbell, Peter J.
Jacobsen, Sten Eirik W.
Hellstroem-Lindberg, Eva
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2749.2749
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2749
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
    Song, Jinming
    Moscinski, Lynn
    Zhang, Hailing
    Zhang, Xiaohui
    Hussaini, Mohammad
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (01) : 91 - 98
  • [2] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
    Song, Jinming
    Hussaini, Mohammad
    Talha, Rashid
    Zhang, Hailing
    Zhang, Ling
    Shao, Haipeng
    Zhang, Xiaohui
    Moscinski, Lynn
    LABORATORY INVESTIGATION, 2017, 97 : 379A - 379A
  • [3] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
    Song, Jimning
    Hussaini, Mohammad
    Talha, Rashid
    Zhang, Hailing
    Zhang, Ling
    Shao, Haipeng
    Zhang, Xiaohui
    Moscinski, Lynn
    MODERN PATHOLOGY, 2017, 30 : 379A - 379A
  • [4] Somatic Mutations in TET2, but Not SF3B1, Are Prevalent during Normal Aging Hematopoiesis in Human
    Buscarlet, Manuel
    Busque, Lambert
    Lepine, Guylaine
    Levine, Ross L.
    BLOOD, 2014, 124 (21)
  • [5] 5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively
    Gackowski, Daniel
    Gawronski, Maciej
    Kerr, Cassandra
    Radivoyevitch, Tomas
    Zarakowska, Ewelina
    Starczak, Marta
    Abakir, Abdulkadir
    Ruzov, Alexey
    Maciejewski, Jaroslaw P.
    Olinski, Ryszard
    HAEMATOLOGICA, 2020, 105 (05) : E213 - E215
  • [6] RARS-T patients are characterized by high frequencies of SF3B1 and JAK2 mutations
    Jeromin, S.
    Haferlach, T.
    Alpermann, T.
    Haferlach, C.
    Kern, W.
    Schnittger, S.
    ONKOLOGIE, 2012, 35 : 30 - 30
  • [7] Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
    Szpurka, Hadrian
    Jankowska, Anna M.
    Makishima, Hideki
    Bodo, Juraj
    Bejanyan, Nelli
    Hsi, Eric D.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    LEUKEMIA RESEARCH, 2010, 34 (08) : 969 - 973
  • [8] SF3B1 MUTATIONS IN MDS-RS ARISE IN MULTIPOTENT HEMOPOETIC STEM CELLS
    Mortera-Blanco, T.
    Dimitriou, M.
    Woll, P. S.
    Elvarsdottir, E.
    Karimi, M.
    Conte, S.
    Jansson, M.
    Douagi, I.
    Papaemmanuil, E.
    Jacobsen, S. E.
    Hellstrom-Lindberg, E.
    HAEMATOLOGICA, 2016, 101 : 159 - 159
  • [9] SF3B1 Mutations in Hematological Malignancies
    Cilloni, Daniela
    Itri, Federico
    Bonuomo, Valentina
    Petiti, Jessica
    CANCERS, 2022, 14 (19)
  • [10] FREQUENCY AND PROGNOSTIC IMPACT OF SF3B1 AND DNMT3A MUTATIONS IN REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS)
    Martin, I.
    Such, E.
    Vicente, A.
    Navarro, B.
    Lopez-Pavia, M.
    Gomez, M.
    Ibanez, M.
    Tormo, M.
    Oltra, S.
    Cervera, J.
    Sanz, G.
    LEUKEMIA RESEARCH, 2015, 39 : S154 - S154
12345